Blood test may spot bone fracture risk better than X-Rays
NCT ID NCT06551155
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new blood-based method to diagnose osteoporosis and predict fracture risk. Researchers will analyze the vitality and behavior of certain blood cells from 120 healthy, osteopenic, and osteoporotic adults aged 40 and older. The goal is to see if this approach is more accurate than current bone density scans (DXA) for identifying different stages of bone loss.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Diagnostic test using peripheral blood mononuclear cells (PBMCs)
What this could lead to
If successful, this could provide a more accurate, blood-based way to diagnose osteoporosis and predict fracture risk, potentially reducing misdiagnosis.
What could go wrong
This is an early-stage diagnostic study with 120 participants, so the test may not prove accurate enough for widespread use. It also requires further validation before becoming a standard tool.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Azienda Ospedaliero Universitaria Policlinico G.Rodolico - San Marco
RECRUITINGCatania, 95123, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Istituto Ortopedico Rizzoli
RECRUITINGBologna, 40136, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••